<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04193644</url>
  </required_header>
  <id_info>
    <org_study_id>MSCW2019</org_study_id>
    <nct_id>NCT04193644</nct_id>
  </id_info>
  <brief_title>Mindfulness and Self-compassion Focussed Walking</brief_title>
  <acronym>MSCW</acronym>
  <official_title>Effects of Various Types of Physical Activity on Tumor-specific Symptoms of Fatigue in Breast Cancer Patients Undergoing Chemotherapy and / or Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sana-Klinikum Lichtenberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Park-Klinik Berlin Weißensee</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vivantes Klinikum am Urban</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Steffen Lohrer Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is evaluating the effects of two training programs (1. Walking, 2.
      Mindfulness and Self-compassion focussed Walking) on tumor-specific symptoms of fatigue in
      women with breast cancer undergoing chemo- and/or radiotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized research study is evaluating the effects of two training programs (1.
      Walking, 2. Mindfulness and Self-compassion focussed Walking (MSCW)) on tumor-specific
      symptoms of fatigue in women with breast cancer undergoing chemo- and/or radiotherapy. The
      results of both groups are compared with each other and with those of a control group.

      The MSCW program combines endurance based physical activity in the form of medically
      controlled walking, as well as standardized, evidence-based mindfulness exercise elements in
      a training program.

      The participants of both active groups (Walking and MSCW) practice for 12 weeks, once a week
      for 60 minutes under the guidance of a trainer in a group and 2 additional times (60 minutes
      each) independently at home.

      The purpose of this study is to prevent a sharp decline in quality of life due to fatigue
      symptoms by participating in the MSCW training program.

      A total of 135 participants will be included in the study. All participants are followed for
      1 year.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 8, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor specific fatigue symptomatology</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Fatigue Assessment Questionnaire (FAQ), minimum value 0, maximum value 60, higher values mean a worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-specific quality of life</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Functional Assessment of Cancer Therapy - Breastcancer (FACT-B), minimum value 0, maximum value 148 for FACT-B total score, minimum value 0, maximum value 28 for subscores, higher values mean a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Compassion</measure>
    <time_frame>Change from baseline to 6, 12, 24 and 52 weeks</time_frame>
    <description>Self-Compassion Scale German (SCS-D), minimum value 1, maximum value 5 for SCS-D total score, minimum value 1, maximum value 5 for subscores, higher values mean a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>Change from baseline to 6, 12, 24 and 52 weeks</time_frame>
    <description>Southampton Mindfulness Questionnaire (SMQ), minimum value 0, maximum value 96 for SMQ total score, minimum value 0, maximum value 24 for subscores, higher values mean a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS), minimum value 0, maximum value 42 for HADS total score, minimum value 0, maximum value 21 for subscores, higher values mean a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Perceived Stress Scale (PSS), minimum value 0, maximum value 40 for PSS total score, higher values mean a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>State-Trait Anxiety Inventory (STAI) - Trait Dimension, minimum value 10, maximum value 80 for STAI total score, higher values mean a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Polar watch V800</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alpha-Amylase</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>extraction from saliva measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac function parameters</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Examination by sonography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immune defence</measure>
    <time_frame>Change from baseline to 12, 24 and 52 weeks</time_frame>
    <description>Measurement of leukocytes by blood sampling</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Fatigue</condition>
  <arm_group>
    <arm_group_label>Walking-Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group walk 45 minutes 3 times a week (plus 15 minutes of warm up and cool-down) in a moderate intensity range (64-76% HRmax).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness and Self-Compassion focussed Walking-Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group walk 45 minutes 3 times a week (plus 15 minutes of warm up and cool-down) in a moderate intensity range (64-76% HRmax) and additionally practice mindfulness exercises and self-compassion exercises during the 60 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU-Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in this group receive no intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness and Self-Compassion focussed exercises during walking training</intervention_name>
    <description>Mindfulness and Self-Compassion focussed exercises during walking training with moderate intensity</description>
    <arm_group_label>Mindfulness and Self-Compassion focussed Walking-Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Walking training</intervention_name>
    <description>Walking training with moderate intensity</description>
    <arm_group_label>Walking-Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with breast cancer who have started antineoplastic therapy
             (chemotherapy / radiotherapy).

          -  Age ≥18 years

          -  The patient must be able to perform the study intervention (physically and
             psychologically).

          -  oral and written consent to participate in the study.

        Exclusion Criteria:

          -  distant metastases

          -  Severe mental and / or additional organic illnesses

          -  Clinically relevant cardiac arrhythmias or angina pectoris

          -  Severe pulmonary disease

          -  inadequate walking ability or gait disturbance (including neurological deficits,
             endoprosthesis supply that lead to gait insecurity)

          -  regular meditation practice (several times a week)

          -  Planned start of meditation, relaxation, MBSR, yoga, Qi Gong courses over the next 24
             weeks.

          -  Participation in other intervention studies on walking or meditation

          -  Insufficient knowledge of the German language
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Ströhle, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Charite Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yves L. Steininger, M.Sc. M.Sc.</last_name>
    <phone>+491635820041</phone>
    <email>yves.steininger@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas Ströhle, Prof.</last_name>
    <phone>+4930450517034</phone>
    <email>andreas.stroehle@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charite Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Steininger, M.Sc. M.Sc.</last_name>
      <phone>01635820041</phone>
      <email>yves.steininger@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Andreas Ströhle, Prof.</last_name>
      <phone>+4930450517034</phone>
      <email>andreas.stroehle@charite.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Sana-Klinikum Lichtenberg, Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Steininger, M.Sc.M.Sc.</last_name>
      <phone>+491635820041</phone>
      <email>yves.steininger@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Kasal</last_name>
      <phone>+491733852791</phone>
      <email>thomas.kasal@gym-tv.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>November 30, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Yves Steininger</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>tumor-specific fatigue syndrome</keyword>
  <keyword>mindfulness</keyword>
  <keyword>self-compassion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

